Inicio>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Telithromycin

Telithromycin

Catalog No.GC15110

La telitromicina (HMR3647) es un nuevo antibiÓtico cetÓlido que se parece estructuralmente a los macrÓlidos.

Products are for research use only. Not for human use. We do not sell to patients.

Telithromycin Chemical Structure

Cas No.: 191114-48-4

Tamaño Precio Disponibilidad Cantidad
1 mg
50,00 $
Disponible
5 mg
126,00 $
Disponible
10 mg
225,00 $
Disponible
25 mg
446,00 $
Disponible
50 mg
720,00 $
Disponible
1g
4.600,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Telithromycin(HMR3647) is a ketolide antibiotic to treat community acquired pneumonia of mild to moderate severity. Target: AntibacterialTelithromycin prevents bacteria from growing, by interfering with their protein synthesis. Telithromycin binds to the subunit 50S of the bacterial ribosome, and blocks the progression of the growing polypeptide chain. Telithromycin has over 10 times higher affinity to the subunit 50S than erythromycin. In addition, telithromycin strongly bind simultaneously to two domains of 23S RNA of the 50 S ribosomal subunit, where older macrolides bind strongly only to one domain and weakly to the second domain. Telithromycin can also inhibit the formation of ribosomal subunits 50S and 30S. From Wikipedia.

References:
[1]. http://en.wikipedia.org/wiki/Telithromycin

Reseñas

Review for Telithromycin

Average Rating: 5 ★★★★★ (Based on Reviews and 1 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Telithromycin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.